Inferior Vena Cava (IVC) Filter Market

The global Inferior Vena Cava (IVC) Filter Market is valued at USD 750.2 Million in 2024 and is projected to reach a value of USD 1840.6 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 8.5% between 2025 and 2035.

The inferior vena cava (IVC) is a major vein responsible for carrying deoxygenated blood from the lower and middle parts of the body to the heart's right atrium. An IVC filter, a small cone-shaped device, is implanted in the vein below the kidneys to trap blood clots, or embolisms, that may travel from the deep veins in the legs to the heart and lungs. These filters have gained prominence over time, as their absence can lead to pulmonary artery blockages caused by embolisms.

Key Highlights

• Based on the Product, the Retrievable IVC Filter category accounted for significant market share in Inferior Vena Cava (IVC) Filter market industry for 56.5% in 2024
• In 2024, by Application, Prevent Pulmonary Embolism (PE) dominated the Inferior Vena Cava (IVC) Filter market with significant market share
• By End User, Hospitals led the Inferior Vena Cava (IVC) Filter market industry with highest market share
• North America dominated the Inferior Vena Cava (IVC) Filter market industry with 46.2% Inferior Vena Cava (IVC) Filter market share in 2024
• Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period in Inferior Vena Cava (IVC) Filter market industry

Product Overview

​The Product segment is divided into Retrievable IVC Filter and Permanent IVC Filter. The Retrievable IVC Filter segment held the Inferior Vena Cava (IVC) Filter market size of 56.5% in 2024.

The Retrievable IVC Filter led the Inferior Vena Cava (IVC) Filter market industry in 2024, capturing over 56.5% of revenue. Retrievable IVC Filter’s leadership is attributed to its growing preference over permanent filters due to its versatility, reduced risk of long-term complications, and advancements in retrieval techniques. The increasing adoption of minimally invasive procedures and improved medical imaging technologies further support the widespread use of retrievable IVC filters, solidifying their position as the Inferior Vena Cava (IVC) Filter market's leading product category.

Application Overview

​The Application segment is divided into Treatment Venous Thromboembolism (VTE), Prevent Pulmonary Embolism (PE) and Others. The Prevent Pulmonary Embolism (PE) segment held the dominant share in 2024, accounting for significant Inferior Vena Cava (IVC) Filter industry share.

The Prevent Pulmonary Embolism (PE) segment led the global Inferior Vena Cava (IVC) Filter industry in 2024 and expected to grow at the fastest rate in the coming years. Pulmonary embolism (PE) occurs when a blood clot blocks an artery in the lung, restricting blood flow to a portion of the lung. These clots typically originate in the legs and travel through the right side of the heart to the lungs. Inferior vena cava (IVC) filters are commonly utilized in managing PE. The segment's growth in Inferior Vena Cava (IVC) Filter market is driven by factors such as the increasing prevalence of pulmonary embolism, a growing geriatric population, and the rising demand for minimally invasive procedures. The high prevalence of PE significantly contributes to the increased use of IVC filters. For example, a study published in Lung India in November 2024 revealed PE prevalence rates of 2% in India and 5% in South Korea, with higher risks observed in patients with conditions like tachycardia, tachypnea, and respiratory alkalosis. Additionally, data from Australia's Department of Health and Aged Care estimated over 17,000 annual cases of PE, with incidence rates climbing as the population ages. Older adults, cancer patients, and individuals with limited mobility, such as those hospitalized, are particularly at risk. Thus, the rising prevalence of PE and the growing geriatric population are expected to significantly boost the adoption of IVC filters, driving segment growth in Inferior Vena Cava (IVC) Filter market industry.

End User Overview

​The End User segment is divided into Hospitals, Ambulatory Surgical Centers (ASCs), Others. The Hospitals segment held the dominant share in 2024, accounting for significant Inferior Vena Cava (IVC) Filter industry share.

The Hospitals segment led the global Inferior Vena Cava (IVC) Filter industry in 2024 and expected to grow at the fastest rate in the coming years driven by the high volume of IVC filter implantation procedures performed in hospital settings, supported by advanced medical infrastructure, skilled healthcare professionals, and the availability of cutting-edge imaging technologies. Additionally, the rising prevalence of venous thromboembolism (VTE) and pulmonary embolism (PE), coupled with the increasing demand for minimally invasive treatments, further boosts the adoption of IVC filters in hospitals. Enhanced patient care services and growing healthcare expenditure are also expected to contribute to the segment's sustained growth in Inferior Vena Cava (IVC) Filter market.

Regional Overview

In 2024, the Inferior Vena Cava (IVC) Filter market size of the North America is USD 346.5 Million.

North America Inferior Vena Cava (IVC) Filter industry report is driven by the growing use of IVC filters for treating venous thromboembolism (VTE) and pulmonary embolism (PE), the rising prevalence of these conditions, and an expanding geriatric population. According to data from the CDC updated in June 2022, up to 900,000 individuals in the United States may be affected by deep vein thrombosis (DVT) or PE annually. This high prevalence is expected to increase the adoption of IVC filters, contributing to market growth. Moreover, as VTE and PE are strongly associated with aging, the growing elderly population in the region is a key factor driving market growth. For example, Statistics Canada data from July 2022 indicates that approximately 7.33 million Canadians, or 18.8% of the population, are aged 65 or older. Therefore, factors such as the increasing prevalence of VTE and PE and the aging population are expected to significantly propel market growth in North America.

U.S. Inferior Vena Cava (IVC) Filter Market Analysis

In 2024, the U.S. led the North American Inferior Vena Cava (IVC) Filter Market, driven by a high prevalence of venous thromboembolism (VTE) and pulmonary embolism (PE), advanced healthcare infrastructure, and widespread adoption of minimally invasive procedures. For instance, as per an article in 2022, the annual incidence of PE ranges from 39 to 115 cases per 100,000 people, while DVT affects 53 to 162 per 100,000 individuals in the U.S., with PE being more common in males than females. The rising incidence of these conditions’ further fuels market expansion. Favorable reimbursement policies and ongoing technological advancements in IVC filter designs further supported the market's growth. Additionally, the rising geriatric population and increasing awareness about VTE prevention contributed to the Inferior Vena Cava (IVC) Filter market's dominance in the region.

Asia Pacific Inferior Vena Cava (IVC) Filter Market Analysis

The Asia Pacific Inferior Vena Cava (IVC) Filter industry report is set for significant growth with over the forecast period fueled by factors such as a growing prevalence of VTE and PE, improving healthcare infrastructure, and increasing investments in medical technology. The rising geriatric population and heightened awareness about VTE management in countries like China and India are also driving demand. Additionally, the region's expanding medical tourism industry and the availability of cost-effective treatment options are expected to accelerate Inferior Vena Cava (IVC) Filter market growth.

Europe Inferior Vena Cava (IVC) Filter Market Analysis

Europe are expected to see Inferior Vena Cava (IVC) Filter industry growth during the forecast period driven by an aging population, increasing prevalence of VTE and PE, and advancements in healthcare technologies. Government initiatives to improve healthcare access and rising adoption of minimally invasive procedures are further boosting the market. Key markets such as Germany, the UK, and France are anticipated to contribute significantly due to their robust healthcare systems and growing demand for innovative medical devices.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Inferior Vena Cava (IVC) Filter Market Trends

• Technological Innovations: Development of next-generation filters with improved biocompatibility, enhanced anchoring systems, and advanced imaging compatibility for precise placement and retrieval
• Rising Incidence of Venous Thromboembolism (VTE): Increasing prevalence of VTE conditions, driven by aging populations and sedentary lifestyles, is boosting demand for IVC filters
• Regulatory Focus and Product Approvals: Stringent regulatory requirements are driving manufacturers to focus on quality improvements, while new product approvals are expanding market offerings
• Litigation and Safety Concerns: Ongoing lawsuits and safety concerns related to complications from older-generation filters are influencing market dynamics and pushing manufacturers toward innovation and transparency
• Focus on Minimally Invasive Procedures: Surgeons and interventional radiologists are increasingly adopting minimally invasive techniques for IVC filter implantation and retrieval, boosting demand for compatible devices

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Market Drivers for Inferior Vena Cava (IVC) Filter Market

Rising Incidence of Deep Vein Thrombosis (DVT)

The growing incidence of deep vein thrombosis (DVT) is a significant driver of Inferior Vena Cava (IVC) Filter market growth. Modern lifestyles, characterized by prolonged periods of immobility due to activities like travel, binge-watching, and extensive use of computers and mobile devices, have increased the risk of blood clots forming in the leg veins. Extended sitting or lack of physical activity disrupts normal blood flow, creating conditions conducive to clot formation. Additionally, factors such as increased stress, poor dietary habits, and rising obesity rates, which are all risk factors for DVT, have led to more individuals experiencing leg clots. Hospitalized patients, especially those undergoing complex surgeries or recovering from severe injuries that require extended bed rest, are particularly at risk. The growing number of surgical procedures and improved access to emergency care have contributed to a rise in DVT cases related to medical interventions.

Market Restraints for Inferior Vena Cava (IVC) Filter market

Stringent Regulatory Approval Process

IVC filters are classified as class III medical devices, requiring extensive clinical testing and pre-market approval from regulatory bodies like the U.S. FDA and the European Medicines Agency (EMA) before they can be commercially launched. The approval process is complex, costly, and time-consuming, often involving clinical trials to demonstrate the safety and efficacy of new IVC filter designs. Any changes to the filter's design, materials, or intended use necessitate additional studies and approvals, which can delay the introduction of new products. The strict regulatory requirements also lead to increased compliance costs for manufacturers and present challenges for companies looking to expand into new markets with varying regulatory standards.

Market Opportunities for Inferior Vena Cava (IVC) Filter market

Development of Retrievable IVC Filters

The development of retrievable IVC filters offers significant growth opportunities in Inferior Vena Cava (IVC) Filter market for industry players. Unlike permanent filters, which remain embedded in the vein, retrievable filters can be inserted and removed once the risk of pulmonary embolism has passed, preventing long-term complications. Clinical evidence increasingly supports the advantages of retrievable filters over permanent ones, driving demand for these devices. Market players are encouraged to invest in research and development to create advanced retrievable filters with improved clinical efficacy, such as reduced risks of fracture or migration. Launching filters that are easier to retrieve and reposition will help companies capture more market share. For example, in February 2023, Cook Medical received FDA approval for its next-generation retrievable IVC filter, the Celect Vena Cava Filter, which offers enhanced flexibility and ease of insertion, along with a retrieval rate exceeding 90%.

Competitive Landscape

The Inferior Vena Cava (IVC) Filter market industry report is marked by the presence of several key players, including prominent medical device manufacturers and emerging companies striving for market share. Companies such as Boston Scientific Corporation, Cook Medical, Becton, Dickinson and Company (BD), and Medtronic are leading the market with advanced product offerings and a strong global presence. These players focus on innovation, strategic collaborations, and regulatory approvals to maintain their competitive edge. The Inferior Vena Cava (IVC) Filter market also sees competition from regional manufacturers who offer cost-effective alternatives, particularly in emerging economies. The increasing adoption of retrievable IVC filters, advancements in filter design, and rising awareness about venous thromboembolism prevention further intensify competition inInferior Vena Cava (IVC) Filter market.

The key players in the global Inferior Vena Cava (IVC) Filter market report include - B. Braun Melsungen AG, VENITI, Inc., Cardinal Health, Inc., C. R. Bard, Braile Biomdica, Boston Scientific Corporation, Cook Medical, Argon Medical Devices, Inc., Koninklijke Philips N.V. (Philips Volcano), ALN among others.

Recent Market Developments

Argon Medical Partners with Terumo India to Expand Interventional Solutions in the Indian Market

• In May 2022, Argon Medical partnered with Terumo India, a renowned global medical technology leader, to introduce its products to the Indian market. This collaboration aims to provide comprehensive solutions across interventional radiology, vascular surgery, interventional cardiology, and clinical oncology

The global Inferior Vena Cava (IVC) Filter market can be categorized as Product, Application, End User and Region.